e-learning
resources
European Respiratory Review
2020
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?
Robert A. Lewis, Charlotte Durrington, Robin Condliffe, David G. Kiely
Source:
Eur Respir Rev, 29 (156) 200009; 10.1183/16000617.0009-2020
Journal Issue:
June
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Robert A. Lewis, Charlotte Durrington, Robin Condliffe, David G. Kiely. BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?. Eur Respir Rev, 29 (156) 200009; 10.1183/16000617.0009-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Pulmonary arterial hypertension or left heart disease with pulmonary hypertension? Toward noninvasive clarity, but time for a new paradigm
Source: Eur Respir J 2015; 46: 299-302
Year: 2015
Goal-oriented therapy in paediatric pulmonary arterial hypertension: are we ready?
Source: Eur Respir J 2014; 44: 1404-1407
Year: 2014
Is right heart catheterisation still a fundamental part of the follow-up assessment of pulmonary arterial hypertension? The argument against
Source: Eur Respir J, 52 (1) 1800996; 10.1183/13993003.00996-2018
Year: 2018
Acute vasodilator testing in idiopathic pulmonary arterial hypertension: must we take NO for the answer?
Source: Eur Respir J 2009; 33: 1247-1249
Year: 2009
Early detection and management of pulmonary arterial hypertension
Source: Eur Respir Rev 2012 21: 306-312
Year: 2012
Cardiopulmonary exercise testing for detection of early pulmonary vascular changes in relatives of patients with idiopathic pulmonary arterial hypertension
Source: Annual Congress 2007 - Clinical aspects of pulmonary arterial hypertension
Year: 2007
Pulmonary haemodynamics during exercise in patients with pulmonary arterial hypertension
Source: Annual Congress 2005 - Exercise testing in pulmonary arterial hypertension
Year: 2005
Use of a telemedicine application for training and follow up of patients with pulmonary arterial hypertension
Source: Annual Congress 2008 - Pulmonary hypertension II
Year: 2008
Exercise testing to predict outcome in idiopathic versus associated pulmonary arterial hypertension
Source: Eur Respir J 2012; 40: 1410-1419
Year: 2012
Heritable pulmonary hypertension: from bench to bedside
Source: Eur Respir Rev, 26 (145) 170037; 10.1183/16000617.0037-2017
Year: 2017
Challenges in the diagnosis and treatment of pulmonary arterial hypertension
Source: Eur Respir Rev 2012 21: 313-320
Year: 2012
Different work load protocols for cardiopulmonary exercize testing in patients with severe pulmonary arterial hypertension
Source: Annual Congress 2004 - Pulmonary hypertension
Year: 2004
Right heart catheterisation is still a fundamental part of the follow-up assessment of pulmonary arterial hypertension
Source: Eur Respir J, 52 (1) 1800738; 10.1183/13993003.00738-2018
Year: 2018
The imPAHct of diagnosis delay in pulmonary arterial hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012
Symptom-related telephone monitoring and cardiopulmonary exercise testing in the pulmonary embolism follow-up for early detection of chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Year: 2013
Pulmonary hypertension and pulmonary arterial hypertension: a clarification is needed
Source: Eur Respir J 2010; 36: 986-990
Year: 2010
Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease
Source: Eur Respir Rev 2011; 20: 236-242
Year: 2011
The value of cardiopulmonary exercise test in assessment of the severity of pulmonary arterial hypertension patients
Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension
Year: 2017
A point-of-care brain natriuretic peptide assay in the risk stratification and management of patients with pulmonary arterial hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 48s
Year: 2006
Pulmonary arterial hypertension: tailoring treatment to risk in the current era
Source: Eur Respir Rev, 26 (146) 170095; 10.1183/16000617.0095-2017
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept